iCAD, Inc. (ICAD) Announces More Than 1,000 Early Stage Breast Cancer Patients Treated With Intraoperative Radiation Therapy (IORT) Using The Xoft System
3/6/2014 9:47:18 AM
NASHUA, N.H. & MIAMI--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced image analysis and radiation therapy solutions for the early identification and treatment of cancer, today announced at the 31st Annual Miami Breast Cancer Conference that more than 1,000 early stage breast cancer patients have been treated with Intraoperative Radiation Therapy (IORT) using the Xoft® Axxent® Electronic Brachytherapy System®. With IORT, a full course of radiation therapy is delivered to the patient in the operating room immediately following lumpectomy, replacing six to eight weeks of daily traditional radiation.
Help employers find you! Check out all the jobs and post your resume.
comments powered by